Tonix Pharmaceuticals Stock Forecast

Buy candidate since May 12, 2025

The Tonix Pharmaceuticals stock price gained 1.91% on the last trading day (Monday, 12th May 2025), rising from $18.83 to $19.19. During the last trading day the stock fluctuated 6.22% from a day low at $18.50 to a day high of $19.65. The price has risen in 6 of the last 10 days and is up by 12.68% over the past 2 weeks. Volume fell on the last day by -82 thousand shares and in total, 370 thousand shares were bought and sold for approximately $7.10 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $15.14 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 36.02% during the next 3 months and, with a 90% probability hold a price between $20.60 and $48.83 at the end of this 3-month period.

TNXP Signals & Forecast

The Tonix Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $19.22. On a fall, the stock will find some support from the long-term average at approximately $18.95. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, March 24, 2025, and so far it has fallen -37.10%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Tonix Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $17.88 and $16.47. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Tonix Pharmaceuticals finds support just below today's level at $17.88. If this is broken, then the next support from accumulated volume will be at $16.47 and $14.63.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.15 between high and low, or 6.22%. For the last week, the stock has had daily average volatility of 6.35%.

Our recommended stop-loss: $18.23 (-5.02%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 34 days ago.)

Trading Expectations (TNXP) For The Upcoming Trading Day Of Tuesday 13th

For the upcoming trading day on Tuesday, 13th we expect Tonix Pharmaceuticals Holding Corp. to open at $19.11, and during the day (based on 14 day Average True Range), to move between $17.35 and $21.03, which gives a possible trading interval of +/-$1.84 (+/-9.57%) up or down from last closing price. If Tonix Pharmaceuticals Holding Corp. takes out the full calculated possible swing range there will be an estimated 19.14% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $20.17 (5.11%) than the support at $17.88 (6.85%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Tonix Pharmaceuticals Holding Corp. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Tonix Pharmaceuticals stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 4.590 Buy Candidate Upgraded

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on May 13, 2025 - $19.11 ( 0.399%).